Hospital News and Research

RSS

Rural hospitals: Does the health law help or hurt?

Some politicians and hospital administrators worry that the new health law will cause rural facilities to lose revenue, bucking the trend of Washington's political establishment's long support for rural hospitals, the Omaha World-Herald reports. The law does have "pro-rural provisions" that received bipartisan support. But as the federal government writes rules for the law, partisan interpretations of the true impact on rural hospitals has continued.

2 Jun 2010

Holon announces entree into healthcare information technology vertical

Holon, the new standard for healthcare interoperability, today announced its entree into the healthcare information technology vertical. Signaling our new direction is the Holon Brand. Holon: (Greek: holos, "whole") is something that is simultaneously a whole and a part, a system that is itself a part of a larger system and signifies the blending of proven technologies with actionable intelligence to measurably improve care.

2 Jun 2010

First Edition: June 2, 2010

In today's news, insurance regulators fail to meet an early deadline for setting standards on premium spending rules within the new health law.

2 Jun 2010

Genes influence AIAA side effect in breast cancer survivors

Aromatase inhibitor-associated arthralgia (AIAA) is a major side effect in breast cancer survivors, producing joint pain so severe that as many as ten percent of women discontinue their therapy prematurely while undergoing treatment with these lifesaving drugs.

2 Jun 2010

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that the launch of Soliris (eculizumab) as a treatment for patients with PNH in Japan will begin in the third quarter of 2010, approximately three months earlier than previously expected.

2 Jun 2010

Heart attack patients treated beyond maximum recommended time have increased mortality: Study

An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.

2 Jun 2010

Functional muscle transfer surgery allows people with foot drop to walk without braces

A new surgery that involves an expendable, functioning muscle from the top of the leg and a nerve below the knee can give people with foot drop a new bounce in their step.

2 Jun 2010

Synthetic peptide repairs, regenerates stroke-injured brain tissue

A synthetic version of a naturally occurring peptide promoted the creation of new blood vessels and repaired damaged nerve cells in lab animals, according to researchers at Henry Ford Hospital in Detroit.

2 Jun 2010

Aegis Health Group offers ten best practices to foster hospital-employer partnerships

In its latest thought paper, "Hospital-Employer Partnerships: Best Practices for Growing Market Share," Aegis Health Group offers ten best practices from hospitals across the country that have fostered mutually beneficial relationships with the employers in their area. Hospital-employer partnerships are proven to be one of the best approaches to efficiently increase market share and enhance revenue to hospitals according to Aegis, the nation's leading strategic revenue growth company for hospitals.

2 Jun 2010

CDRD, Vancouver Prostate Centre announce preferred collaboration agreement

The Centre for Drug Research and Development (CDRD) and the Vancouver Prostate Centre (VPC) today announced that they have signed a preferred collaboration agreement as the two organizations jointly strive to accelerate the discovery, development and commercialization of anti-cancer therapeutics.

2 Jun 2010

Cook Medical's Resonance Metallic Ureteral Stent demonstrates long-term success in 29-month clinical study

A 29-month clinical study demonstrated the long-term success of Cook Medical's Resonance® Metallic Ureteral Stent in providing drainage for patients with both benign and malignant upper urinary tract obstructions, according to results presented today at the 2010 Annual Meeting of the American Urological Association (AUA). The findings suggest that metallic stents provide adequate drainage and can be maintained in situ for 12 months without significant encrustation.

2 Jun 2010

Targeted monoclonal antibodies show promise for pancreatic and metastatic breast cancer

Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators from the University of Pennsylvania's Abramson Cancer Center at the 2010 meeting of the American Society of Clinical Oncology June 4 through 8.

2 Jun 2010

Emerson Ecologics announces awardees of Partner status in Emerson Quality Program

Emerson Ecologics, LLC announces the debut of the first group of manufacturers to be awarded Partner status in the Emerson Quality Program(SM) (EQP). This one-of-a-kind quality assurance program for the nutritional supplements industry provides practitioners with manufacturer-specific quality and safety information to assist in confidently recommending the best products to patients.

2 Jun 2010

New research project to discover origin of myelodysplasia

The University of Navarra, together with the University of Oxford and three other European centres, are taking part in a project to discover the origin of myelodysplasia, an ailment with a predisposition to develop into leukaemia. In the work, patients from 19 hospitals in the north of Spain - including the University Hospital of Navarra - were analysed, as well as from England, Italy, Sweden and Germany.

2 Jun 2010

Men who refuse surgery for prostate cancer have 51% overall survival rate: Study

Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" - monitoring cancer progression without undergoing treatment - have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in Detroit.

2 Jun 2010

Texas Heart Institute at St. Luke's Episcopal Hospital performs 1000th carotid artery stent procedure

The Texas Heart Institute (THI) at St. Luke's Episcopal Hospital has announced another major milestone in improved patient care, after performing its 1000th carotid artery stent procedure. Carotid artery stenting (CAS) has emerged as a less invasive treatment for stroke-causing blockages in the carotid artery, meaning patients generally have fewer risks for complications, shorter hospital stays and recovery times and less expense.

2 Jun 2010

Santarus commences enrollment in rifamycin SV MMX Phase III clinical program for travelers' diarrhea

Santarus, Inc., a specialty biopharmaceutical company, today announced that is has begun to enroll patients in the first study in its Phase III clinical program to evaluate the efficacy and safety of rifamycin SV MMX® for the treatment of patients with travelers' diarrhea.

2 Jun 2010

High oxygen delivery after postcardiac arrest leads to higher rate of death in hospitals

Patients who have excessive oxygen levels in arterial blood (hyperoxia) following resuscitation from cardiac arrest have a higher rate of death in the hospital than similar patients without arterial hyperoxia, according to a study in the June 2 issue of JAMA.

2 Jun 2010

Curemark commences clinical trial enrollment for CM-AT autism treatment at two more sites

Curemark, LLC,, a drug research and development company focused on the treatment of neurological diseases, announced that the company has opened clinical trial enrollment for CM-AT, its autism treatment, at the University of Pittsburgh and the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois, near Chicago. A total of 12 sites nationwide are recruiting patients for CM-AT Phase III clinical trials.

2 Jun 2010

Healthcare facilities lack appropriate equipment, supplies to manage emergency situations: Report

Healthcare facilities sometimes lack the appropriate equipment and supplies to successfully manage an emergency in their facility in a timely manner, according to data released today by the Pennsylvania Patient Safety Authority and published in the June Pennsylvania Patient Safety Advisory.

2 Jun 2010

Hospital News and Research

Rural hospitals: Does the health law help or hurt?

Holon announces entree into healthcare information technology vertical

First Edition: June 2, 2010

Genes influence AIAA side effect in breast cancer survivors

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Heart attack patients treated beyond maximum recommended time have increased mortality: Study

Functional muscle transfer surgery allows people with foot drop to walk without braces

Synthetic peptide repairs, regenerates stroke-injured brain tissue

Aegis Health Group offers ten best practices to foster hospital-employer partnerships

CDRD, Vancouver Prostate Centre announce preferred collaboration agreement

Cook Medical's Resonance Metallic Ureteral Stent demonstrates long-term success in 29-month clinical study

Targeted monoclonal antibodies show promise for pancreatic and metastatic breast cancer

Emerson Ecologics announces awardees of Partner status in Emerson Quality Program

New research project to discover origin of myelodysplasia

Men who refuse surgery for prostate cancer have 51% overall survival rate: Study

Texas Heart Institute at St. Luke's Episcopal Hospital performs 1000th carotid artery stent procedure

Santarus commences enrollment in rifamycin SV MMX Phase III clinical program for travelers' diarrhea

High oxygen delivery after postcardiac arrest leads to higher rate of death in hospitals

Curemark commences clinical trial enrollment for CM-AT autism treatment at two more sites

Healthcare facilities lack appropriate equipment, supplies to manage emergency situations: Report

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News